Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Longboard Pharmaceuticals Inc | LBPH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 19.25 | 05:54:09 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 19.25 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 3.60 - 28.15 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 19.25 | USD |
Longboard Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 693.33M | 36.02M | - | 0 | -54.42M | -1.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Longboard Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LBPH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.69 | 20.72 | 17.31 | 18.98 | 417,666 | 1.56 | 8.82% |
| 1 Month | 21.90 | 21.90 | 16.55 | 18.76 | 391,131 | -2.65 | -12.10% |
| 3 Months | 20.67 | 24.50 | 16.55 | 20.10 | 543,237 | -1.42 | -6.87% |
| 6 Months | 5.42 | 28.15 | 3.60 | 22.48 | 847,697 | 13.83 | 255.17% |
| 1 Year | 7.27 | 28.15 | 3.60 | 20.99 | 466,879 | 11.98 | 164.79% |
| 3 Years | 10.10 | 28.15 | 2.70 | 19.28 | 175,974 | 9.15 | 90.59% |
| 5 Years | 16.00 | 28.15 | 2.70 | 19.20 | 173,694 | 3.25 | 20.31% |
Longboard Pharmaceuticals Description
| Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Its pipeline includes LP352, LP143, and LP659. |
